Skip to main content
Equibles

NEUBERGER BERMAN GROUP LLC

Position in GMAB — Genmab A/S

CIK 1465109 NEW YORK, NY
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,388,800
-$58,999 QoQ
Shares Held
50,557
-6.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 292 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NEUBERGER BERMAN GROUP LLC holds $1,467,551,041 across 98 Biotechnology names. GMAB ranks #40 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 559,445 $277,893,114
2 REGN
Regeneron Pharmaceuticals, Inc.
 421,976 $263,118,914
3 TECH
BIO-TECHNE Corp
 2,844,692 $200,977,489
4 LGND
Ligand Pharmaceuticals Inc
 248,355 $78,502,531
5 CAI
Caris Life Sciences, Inc.
 3,590,963 $63,990,960
6 IONS
Ionis Pharmaceuticals Inc
 633,533 $50,232,830
7 BBIO
BridgeBio Pharma, Inc.
 552,158 $41,124,727
8 INSM
INSMED Inc
 378,816 $40,389,361

All Filings in GMAB

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,388,800 50,557
2026-03-31 $1,447,799 53,962
2025-12-31 $1,753,166 56,921
2025-09-30 $1,419,683 46,289
2025-06-30 $972,941 47,093
2025-03-31 $867,197 44,290
2024-12-31 $702,776 33,674
2024-09-30 $1,073,280 44,023
2024-06-30 $1,209,255 48,120
2024-03-31 $1,502,019 50,218
2023-12-31 $1,244,784 39,095
2023-09-30 $1,557,593 44,162